Chong Li

机构：Union Hospital, Army Medical University, Anhui Medical University, Soochow University, Ya'an Polytechnic College, Beijing Biocytogen (China), The First People's Hospital of Changzhou, Southwest Hospital, Second Affiliated Hospital of Anhui Medical University, Changzhou No.2 People's Hospital, Huazhong University of Science and Technology, Taizhou University · ORCID：0000-0002-9215-6779

发表论文 85 篇 · 总被引 831 次 · h-index 15

代表论文

• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 63)
• CDK4/6 inhibitor PD-0332991 suppresses hepatocarcinogenesis by inducing senescence of hepatic tumor-initiating cells (2024 · Journal of Advanced Research · 被引 14)
• Phase I/II Study of Tifcemalimab, an Anti–B- and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer (2025 · Clinical Cancer Research · 被引 5)
• Molecular Epidemiological Characteristics of blaIMP-4-Carrying Klebsiella pneumoniae ST-11 in Hospitalized Patients (2025 · Infection and Drug Resistance · 被引 4)
• Palliative Care Educational App for Family Caregivers of Homebound Patients With Incurable Cancer (2025 · Annals of Internal Medicine · 被引 2)
• Bypass the Brain: Deep Cervical Lymphatic-Venous Anastomosis Restores the Default Mode Network in Late-stage Alzheimer's Disease (2025 · Research Square · 被引 1)